Renaissance Technologies LLC just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though Renaissance Technologies LLC claims to own 1,480,819 shares. This represents 6.97% of Ligand Pharmaceuticals Incorporated.
Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.
To receive a free e-mail notification whenever Ligand Pharmaceuticals Incorporated makes a similar move, sign up!
Other recent filings from the company include the following: